1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow Episodic Ataxia, Type 2: new trials by email Literature Review of Episodic Ataxia, Type 2 trials Research Report on Episodic Ataxia, Type 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pivotal Study of N-acetyl-L-leucine for CACNA1A N-Acetyl-L-Leucine, Placebo - CACNA1A, Spinocerebellar Ataxia Type 6 | Phase 3 | Active not recruiting | IntraBio Inc | 60 | 2026-08-17 | 2026-11-03 |
Ataxia (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Cerebellar Ataxia (1) · Cerebellar Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Dyskinesias (1) · Genetic Diseases, Inborn (1) · Heredodegenerative Disorders, Nervous System (1) · Nervous System Diseases (1) · Neurodegenerative Diseases (1) · Neurologic Manifestations (1) · Spinal Cord Diseases (1) · Spinocerebellar Degenerations (1)
acetylleucine (1)
IntraBio Inc (1)
Austria (1) · Germany (1) · Greece (1) · Italy (1) · Switzerland (1) · United Kingdom (1) · United States (1)
2025 (1)